SEC Filings - LAVA Therapeutics N.V.

Filing date	Form	Description	Filing Group	View
Feb 24, 2023	SC 13D/A	An amendment to a SC 13D filing	Other	0001193125-23-048834.pdf 0001193125-23-048834.rtf 0001193125-23-048834.xls View HTML
Feb 16, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-001409.pdf 0001558370-23-001409.rtf 0001558370-23-001409.xls View HTML
Feb 06, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-000889.pdf 0001558370-23-000889.rtf 0001558370-23-000889.xls View HTML
Jan 09, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-000113.pdf 0001558370-23-000113.rtf 0001558370-23-000113.xls View HTML
Jan 06, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-23-000091.pdf 0001558370-23-000091.rtf 0001558370-23-000091.xls View HTML
Jan 04, 2023	UPLOAD	UPLOAD	Other	0000000000-23-000092.pdf 0000000000-23-000092.rtf View HTML
Dec 23, 2022	20-F/A	Amendment to a previously filed 20-F	Annual Filings	0001558370-22-018966.pdf 0001558370-22-018966.rtf 0001558370-22-018966.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Dec 12, 2022	CORRESP	CORRESP	Other	0001558370-22-018553.pdf 0001558370-22-018553.rtf 0001558370-22-018553.xls View HTML
Nov 29, 2022	UPLOAD	UPLOAD	Other	0000000000-22-012866.pdf 0000000000-22-012866.rtf View HTML
Nov 16, 2022	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001558370-22-018001.pdf 0001558370-22-018001.rtf 0001558370-22-018001.xls View HTML

Data provided by Kaleidoscope.